Rising India Inc (OTCMKTS:RSII) reported that it will associate with PAO GROUP INC (OTCMKTS:PAOG) Alternative Medicine Facilities of America to provide a free trial of Cannophen™ to people in Ohio. Anyone with a legal Ohio recommendation can file for the trial at their Ohio clinics; this will be closed on a patient to patient basis.
Arthur Hall, the COO of Rising India, expressed that this marks as a monumental event for their firm and one that matters quite a bit to him personally. He has been utilizing Cannophen™ since its earliest advancement stages in anticipations to discover and explore its beneficial properties. Initially he was taking for indications of Parkinson’s and was amazed by overall results.
He had also been fighting cancer for a while now and via surgery, limited chemotherapy and the application of Cannophen™ he is now cancer free. His physicians are fine with the continued application of Cannophen™ for maintenance. They are grateful to be disclosing this information with other patients starting with the plan in Ohio I also will be talking with a Processor/Producer in California that has shown serious interest in distributing and licensing Cannophen™ and other Rising products.
Mounting evidence demonstrates ‘cannabinoids’ in pot slow cancer growth, prevent formation of new blood cells that nourish a tumor, and help manage fatigue, nausea, pain and other side effects. As per The National Cancer Institute, trials in rats and mice have demonstrated that cannabinoids may prevent tumor growth by resulting in cell death, obstructing cell growth, and blocking the advancement of blood vessels required by tumors to grow.
Laboratory and animal trials have demonstrated that cannabinoids can kill cancer cells while safeguarding normal cells. Also, Rising Biosciences is approaching completion on its FDA assessment of the TSW pain cream items and is presently working with a firm for national supply of its Scar Peptide Serum.